Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system

CHING-YAO YANGJIN-YUAN SHIHWEI-YU LIAOCHAO-CHI HOCHIA-LIN HSUTZU-HSIU TSAISHANG-GIN WUYEN-TING LINHsu, Wei-HsunWei-HsunHsuJain, SuyogSuyogJainOlsen, SteveSteveOlsenCHIH-HSIN YANGCHONG-JEN YUPAN-CHYR YANG2023-09-282023-09-282023-08-2809598049https://scholars.lib.ntu.edu.tw/handle/123456789/635861Next-generation sequencing (NGS) of plasma cell-free DNA identifies driver mutations in advanced non-small cell lung cancer (NSCLC) and may complement routine molecular evaluation. The utility of liquid NGS at the start of tumour workup is undetermined.enCfDNA; Liquid biopsy; Lung cancer; NGSUpfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health systemjournal article10.1016/j.ejca.2023.113310377222702-s2.0-85171426343https://api.elsevier.com/content/abstract/scopus_id/85171426343